Research

rs4073 — IL8 -251A>T

Promoter variant affecting interleukin-8 transcription and inflammatory burden

Strong Risk Factor

Details

Gene
IL8
Chromosome
4
Risk allele
A
Consequence
Regulatory
Inheritance
Codominant
Clinical
Risk Factor
Evidence
Strong
Chip coverage
v3 v4 v5

Population Frequency

AA
13%
AT
51%
TT
36%

Ancestry Frequencies

south_asian
62%
east_asian
55%
latino
38%
european
36%
african
14%

The Inflammatory Architect — How a Promoter Variant Shapes Your Cardiovascular Risk

Interleukin-8 (IL-8), also called CXCL8, is one of the body's most powerful chemokines — chemical signals that recruit neutrophils and other immune cells to sites of inflammation. This variant sits in the promoter region11 promoter region
The promoter is the "on switch" for a gene, controlling how much protein gets made
of the IL8 gene at position -251, where it directly influences how much IL-8 your cells produce when triggered by inflammatory stimuli like bacterial endotoxin or tissue damage. The A allele increases IL-8 transcription, leading to higher circulating levels during inflammation — and potentially a greater cumulative inflammatory burden over a lifetime.

This matters because chronic low-grade inflammation is now recognized as a central driver of atherosclerosis, the process where arterial plaques form and grow. IL-8 doesn't just mark inflammation; it actively participates in every stage of atherosclerosis22 every stage of atherosclerosis
From endothelial activation to plaque rupture and thrombosis
, recruiting inflammatory cells into artery walls, promoting plaque instability, and contributing to the acute events that cause heart attacks. Individuals carrying the A allele may experience elevated IL-8 production throughout life, translating to measurably higher cardiovascular risk — particularly in populations of East Asian ancestry.

The Mechanism

The rs4073 variant is a T-to-A substitution located precisely at the transcription factor binding site in the IL8 gene promoter. This position overlaps with NF-κB and other transcription factor binding regions33 NF-κB and other transcription factor binding regions
NF-κB (nuclear factor kappa B) is the master regulator of inflammatory gene expression
that control how strongly the gene responds to inflammatory signals. When your immune system detects a threat — infection, tissue damage, oxidized LDL cholesterol in artery walls — it activates NF-κB, which binds to the IL8 promoter and turns on transcription.

The A allele alters this binding affinity, resulting in stronger transcriptional activation compared to the T allele. In vitro studies show that cells carrying the A allele produce significantly more IL-8 protein when stimulated with lipopolysaccharide44 significantly more IL-8 protein when stimulated with lipopolysaccharide, a bacterial toxin that mimics infection. This isn't a subtle difference — it's a meaningful shift in how aggressively your inflammatory machinery responds to triggers. The AA genotype consistently shows the highest IL-8 levels, AT shows intermediate levels, and TT shows the lowest.

Once secreted, IL-8 acts as a powerful neutrophil chemoattractant. It binds to CXCR1 and CXCR2 receptors on neutrophils and monocytes, guiding them along concentration gradients toward inflamed tissues. In the context of atherosclerosis, this means more immune cells infiltrating arterial plaques, releasing proteases that destabilize the fibrous cap, and increasing the risk of plaque rupture and thrombosis.

The Evidence

The cardiovascular implications of rs4073 have been rigorously studied in multiple populations. A 2019 meta-analysis55 A 2019 meta-analysis
Wang et al., published in Medical Science Monitor
pooled data from 9 studies comprising 8,244 patients and found that the A allele was significantly associated with increased coronary artery disease (CAD) risk across multiple genetic models: dominant model (AA + AT vs TT) showed OR 1.42 (95% CI 1.16–1.76, P<0.001), recessive model (AA vs AT + TT) showed OR 1.30 (95% CI 1.12–1.52, P<0.001), and the homozygote model (AA vs TT) showed OR 1.59 (95% CI 1.21–2.08, P<0.001). The effect was strongest in East Asian populations and absent in Caucasians, suggesting ethnic-specific modulation by genetic background or environmental factors.

A second meta-analysis66 A second meta-analysis
Published in Gene, examining 3,752 cases and 4,219 controls
confirmed these findings: the AA genotype conferred a 26% increased risk of CAD compared to TT (OR 1.26, 95% CI 1.01–1.56, P=0.037). The allelic model showed OR 1.14 (95% CI 1.02–1.27, P=0.02), and the recessive model showed OR 1.15 (95% CI 1.03–1.27, P=0.01). Notably, the association was robust in East Asian subgroups but inconsistent in Caucasians, with high heterogeneity in the latter group.

Population studies77 Population studies
North Indian case-control study, n=300 cases and 300 controls
have replicated these findings outside East Asia, demonstrating that the association is not limited to a single ancestry but may be modified by population-specific haplotype structure and environmental exposures. The A allele has also been linked to higher IL-8 serum levels in Chinese sepsis patients and worse prognosis in gastric cancer88 higher IL-8 serum levels in Chinese sepsis patients and worse prognosis in gastric cancer, underscoring its functional impact on inflammatory phenotypes across diseases.

Mechanistic studies99 Mechanistic studies
Biomarker meta-analyses including 175,778 individuals
show that elevated inflammatory markers, including IL-8, independently predict cardiovascular events even after adjusting for traditional risk factors like LDL cholesterol and blood pressure. This positions IL-8 as both a mechanistic contributor and a prognostic biomarker, with genetic variants like rs4073 serving as lifelong modulators of this pathway.

Practical Actions

For individuals carrying the A allele, the goal is to minimize cumulative inflammatory burden through targeted diet, supplementation, lifestyle modifications, and biomarker monitoring. Omega-3 fatty acids (EPA and DHA)1010 Omega-3 fatty acids (EPA and DHA)
Meta-analyses demonstrate consistent anti-inflammatory effects at 1–3 g/day doses
have been shown to significantly reduce circulating IL-6, IL-1β, and TNF-α in randomized controlled trials, with IL-6 decreasing by 22% after 8 weeks of EPA+DHA supplementation. While IL-8 was not directly measured in these trials, the omega-3 lipid mediators resolvin E1 and protectin D1 inhibit neutrophil transendothelial migration and reduce IL-1β and TNF production — pathways that directly intersect with IL-8 signaling.

Mediterranean dietary patterns1111 Mediterranean dietary patterns
Long-term PREDIMED trial showed sustained reductions in inflammatory biomarkers
have demonstrated robust anti-inflammatory effects, including significant reductions in plasma IL-8 levels after 3 years of adherence. The mechanisms involve polyphenol-rich extra-virgin olive oil suppressing NF-κB signaling, thereby reducing transcription of IL-8 and other pro-inflammatory cytokines. Nuts, fatty fish, and abundant vegetables further contribute through antioxidant and fiber-mediated pathways.

Aerobic exercise1212 Aerobic exercise
Systematic reviews of randomized controlled trials in healthy adults
produces consistent reductions in IL-6, TNF-α, and CRP, with long-term training (>12 weeks) showing the most robust effects. Physical activity interventions specifically reduce IL-8 biomarkers, likely through improved endothelial function, enhanced mitochondrial efficiency, and reduced visceral adiposity. Combined aerobic and resistance training appears optimal for lowering arterial stiffness and inflammatory markers.

Statins, particularly atorvastatin and rosuvastatin1313 atorvastatin and rosuvastatin
Rosuvastatin 20 mg/day more effective than atorvastatin 40 mg/day at lowering CRP
, exert potent anti-inflammatory effects beyond their LDL-lowering action. Atorvastatin markedly decreases NLRP3 inflammasome activation and plasma IL-1β and IL-18 levels. For individuals with the AA genotype and additional cardiovascular risk factors, a statin may provide dual benefit: lipid reduction and inflammation suppression.

Biomarker monitoring is particularly valuable. High-sensitivity CRP (hsCRP)1414 High-sensitivity CRP (hsCRP)
Strongly predicts recurrent cardiovascular events with linear risk between 1–5 mg/L
is the most validated inflammatory biomarker for cardiovascular risk stratification. While IL-8 is not routinely measured clinically, hsCRP serves as a proxy for systemic inflammation and can guide treatment intensity. Individuals with elevated hsCRP despite optimal LDL may particularly benefit from intensified anti-inflammatory interventions.

Finally, smoking cessation is non-negotiable1515 smoking cessation is non-negotiable
Smokers secrete significantly higher IL-8 levels from whole blood ex vivo
. Smoking induces chronic elevation of IL-8 and CRP, amplifying the genetic predisposition conferred by the A allele. Heavy alcohol intake similarly increases inflammatory burden, though moderate consumption (≤1 drink/day) may have neutral or mildly anti-inflammatory effects.

Interactions

The IL-8 pathway does not act in isolation. Gene-gene interactions with IL-6 (rs1800795), TNF-α (rs1800629), and CRP gene variants1616 Gene-gene interactions with IL-6 (rs1800795), TNF-α (rs1800629), and CRP gene variants
IL-6 associations remained significant after adjusting for CRP, but not vice versa
modulate overall inflammatory tone. IL-6 receptor haplotypes, for instance, regulate circulating levels of CRP, fibrinogen, IL-8, and soluble IL-6 receptor across multiple populations. Individuals carrying risk alleles in multiple inflammatory genes may experience compounded effects, while protective variants in one gene may partially offset risk from another.

Within the IL8 gene itself, rs4073 exists on haplotypes with rs2227307 (intron +396T>G) and rs2227306 (exon +781C>T)1717 rs2227307 (intron +396T>G) and rs2227306 (exon +781C>T)
. The haplotype structure differs between East Asians and Caucasians, which may partly explain the ethnic variation in disease associations. The rs2227306 variant, located in exon 1, influences IL-8 at both mRNA and protein levels, potentially amplifying the transcriptional effects of rs4073 when inherited together.

Post-surgical inflammation represents a clinically relevant interaction. IL-8 is a strong predictor of acute kidney injury and need for inotropic support following cardiac surgery1818 a strong predictor of acute kidney injury and need for inotropic support following cardiac surgery, correlating with cardiopulmonary bypass time and surgical complexity. Individuals with the AA genotype may experience exaggerated inflammatory responses to surgical trauma, warranting closer postoperative monitoring and potentially more aggressive perioperative anti-inflammatory strategies.

Nutrient Interactions

omega-3 increased_need

Genotype Interpretations

What each possible genotype means for this variant:

TT “Low Inflammatory Response” Normal

Standard IL-8 transcription and baseline inflammatory response

You carry two copies of the T allele, which is associated with normal IL-8 transcription levels in response to inflammatory stimuli. About 36% of people of European descent and approximately 20% of East Asians share this genotype. Your IL-8 production follows the typical pattern — neither amplified nor suppressed — meaning your baseline inflammatory burden from this pathway is average. This genotype was used as the reference category in cardiovascular studies and showed no increased risk of coronary artery disease.

AT “Intermediate Inflammatory Response” Intermediate Caution

Modestly elevated IL-8 production and slightly increased cardiovascular risk

The heterozygous state represents a gene dosage effect: one high-activity promoter allele (A) and one standard-activity allele (T) produce an intermediate IL-8 phenotype. While not as pronounced as the AA genotype, the AT combination still shifts your inflammatory set point upward. In the context of other cardiovascular risk factors (smoking, diabetes, elevated LDL, family history), this genetic predisposition may tip the scales toward earlier or more aggressive atherosclerosis.

Population frequency varies significantly by ancestry: about 51% in Europeans, 50% in East Asians, and 48% in South Asians. The cardiovascular risk conferred by this genotype is modified by ethnicity, with East Asians showing stronger associations than Caucasians — possibly due to differences in haplotype structure, linkage disequilibrium with other functional variants, or gene-environment interactions.

Your inflammatory response is neither the lowest nor the highest, but it is measurably elevated. This makes you a good candidate for preventive interventions that target inflammation directly, particularly if you have additional risk factors.

AA “High Inflammatory Response” High Warning

Significantly elevated IL-8 production and increased cardiovascular risk

The AA genotype represents the maximal gene dosage effect: both copies of your IL8 promoter are high-activity variants, resulting in amplified transcription whenever inflammatory pathways are activated. This doesn't mean you're constantly inflamed, but rather that your inflammatory "thermostat" is set higher. Each infection, each oxidized LDL particle in your arteries, each bout of metabolic stress triggers a stronger IL-8 response than someone with the TT genotype.

Over a lifetime, this translates to greater cumulative inflammatory burden. IL-8 actively participates in atherosclerosis by recruiting neutrophils and monocytes into arterial plaques, promoting endothelial dysfunction, destabilizing fibrous caps, and increasing the risk of plaque rupture and thrombosis. The 59% increased risk of coronary artery disease (compared to TT) observed in meta-analyses is substantial and comparable to moderate elevations in LDL cholesterol.

The ethnic variation in effect size is striking: East Asians with the AA genotype show particularly strong associations with CAD, while Caucasian studies show more heterogeneity. This may reflect differences in haplotype structure (co-inheritance of rs4073 with other functional IL8 variants like rs2227307), gene-environment interactions, or population- specific modifiers in the inflammatory cascade.

Your genotype also influences non-cardiovascular phenotypes. The A allele has been associated with worse prognosis in gastric cancer, increased susceptibility to idiopathic pulmonary fibrosis, and higher risk of CNS toxicity during tuberculosis treatment — all conditions where excessive inflammation drives pathology.

The good news: inflammation is modifiable. Unlike structural variants that directly impair enzyme function, rs4073 affects transcriptional regulation, which can be influenced by diet, supplements, exercise, and medications. Omega-3 fatty acids, Mediterranean dietary patterns, aerobic exercise, and statins all target the NF-κB and inflammatory cytokine pathways upstream and downstream of IL-8, effectively dampening the genetically elevated inflammatory response.

Key References

PMID: 30826813

Meta-analysis of 8,244 patients showing IL-8 -251 A allele increases CAD risk (OR 1.42) in dominant model, particularly in East Asians

PMID: 31770200

Meta-analysis of 3,752 cases and 4,219 controls confirming AA genotype has 26% increased CAD risk with ethnic variation

PMID: 30073578

North Indian study demonstrating IL-8 -251 A/T polymorphism significantly associated with increased CAD susceptibility

PMID: 34801448

Meta-analysis of 175,778 individuals showing inflammatory biomarkers including IL-8 provide added prognostic value for cardiovascular events

PMID: 24026779

Large prospective study and meta-analysis examining inflammatory cytokines and coronary heart disease risk